Article Versions Notes

Binyamin Y, Frenkel A, Gruzman I, Lerman S, Bichovsky Y, Zlotnik A, Stav MY, Erez O, Orbach-Zinger S. Prophylactic Administration of Tranexamic Acid Reduces Blood Products’ Transfusion and Intensive Care Admission in Women Undergoing High-Risk Cesarean Sections. Journal of Clinical Medicine. 2023; 12(16):5253. https://doi.org/10.3390/jcm12165253

Binyamin, Yair, Amit Frenkel, Igor Gruzman, Sofia Lerman, Yoav Bichovsky, Alexander Zlotnik, Michael Y. Stav, Offer Erez, and Sharon Orbach-Zinger. 2023. "Prophylactic Administration of Tranexamic Acid Reduces Blood Products’ Transfusion and Intensive Care Admission in Women Undergoing High-Risk Cesarean Sections" Journal of Clinical Medicine 12, no. 16: 5253. https://doi.org/10.3390/jcm12165253

Binyamin, Y., Frenkel, A., Gruzman, I., Lerman, S., Bichovsky, Y., Zlotnik, A., Stav, M. Y., Erez, O., & Orbach-Zinger, S. (2023). Prophylactic Administration of Tranexamic Acid Reduces Blood Products’ Transfusion and Intensive Care Admission in Women Undergoing High-Risk Cesarean Sections. Journal of Clinical Medicine, 12(16), 5253. https://doi.org/10.3390/jcm12165253